Market Access Development
Market access is no longer a support function. It is where therapy adoption is won or lost. WLH’s Market Access Development programs equip teams with the channel fluency, payer understanding, negotiation capability, and organized customer engagement skills required to navigate IDNs, GPOs, reimbursement complexity, and value-based healthcare environments with confidence and credibility.
Overview
The decisions that determine whether a therapy reaches patients are no longer made in physician offices. Payer committees, IDN formulary groups, GPO contracting teams, and health system leadership now control access at scale — and the professionals who engage them need a fundamentally different skill set than the field teams that came before them.
WLH’s Market Access Development programs build the channel fluency, customer engagement skills, and business acumen needed to navigate this environment from understanding payer and reimbursement dynamics to engaging organized customers compliantly and with confidence.
Who We Help
- Market access teams engaging organized customers
- Teams navigating IDNs, GPOs, ACOs, and complex health systems
- Access-facing roles translating coverage dynamics into account-specific engagement strategies
PROGRAMS
Capability Development for a Complex Access Environment
Each program is modular and configurable — deployed individually, or sequenced as a complete learning academy.
Market Access
Channel Strategy
Build the understanding of distribution channels, site-of-care dynamics, and provider economics needed to align channel decisions with access strategy across care settings.
Stakeholder Engagement
Organized Customers
Build the profiling and engagement skills to navigate IDNs, GPOs, ACOs, and complex health systems through stakeholder mapping, cross-functional coordination, and account engagement strategies tailored to each customer’s decision-making structure.
Access Strategy
Payer Strategy
Build the knowledge to interpret payer decision drivers and translate coverage dynamics into compliant, account-specific engagement strategies grounded in real-world access realities.
Access Strategy
Reimbursement Strategy
Build the working knowledge of coding, billing, and patient affordability dynamics needed to identify reimbursement barriers and support sustained therapy utilization.
Value Communication
Negotiation Skills
Build the skills to structure value-based agreements and navigate trade-offs with payers, IDNs, GPOs, and hospital systems while maintaining compliant, evidence-grounded positioning.
Market Access
Business of Oncology
Build the business acumen to understand oncology practice economics and workflow, enabling clinical discussions grounded in the financial, operational, and patient access dynamics that drive treatment decisions.
CHALLENGES
Why Market Access Teams Struggle to Navigate Complexity
A Landscape That Has Changed Faster Than the Teams Calling on It
IDN consolidation, GPO influence, ACO formation, and the shift to value-based reimbursement have fundamentally changed who controls access decisions. Market access teams that still operate with a pre-consolidation mindset misread the customer, misallocate effort, and engage at the wrong level.
Organized Customers Treated Like Bigger Accounts, Not Different Ones
Health systems, payers, and GPOs require a different engagement model than traditional account selling. Teams without the stakeholder mapping, cross-functional coordination, and account engagement skills to navigate these environments default to surface-level relationships that do not convert to access or pull-through.
Payer and Reimbursement Complexity That Stalls Utilization
Coverage barriers, coding gaps, and patient affordability dynamics are the invisible obstacles between clinical intent and actual therapy use. When market access teams cannot diagnose and address these barriers, approved therapies go underutilized regardless of clinical merit.
Negotiations That Concede Value Because Teams Aren’t Prepared
Without the skills to structure value-based agreements and navigate trade-offs with payers and organized customers, teams either give away too much or position inaccurately, creating access gaps, compliance risk, and missed contracting opportunities.
Approach
Approach
Every program starts with a diagnostic. We don’t design market access programs until we understand the capability gaps, role requirements, and business context driving the need.
Assess
Evaluate leadership capability against the specific competencies that drive commercial and medical performance using 360° assessments, diagnostic interviews, and manager input to identify what's actually needed.
Design
Build customized programs that integrate real pharma and biotech business challenges, peer learning, and application to live field situations — not generic leadership theory adapted for pharma and biotech.
Implement
Deploy multi-touch learning journeys with embedded practice, manager reinforcement, and real-world application over time — so capability builds in the field, not just in the classroom.
Measure
Track leadership impact through behavior change, team performance, and business outcomes — not satisfaction scores — to demonstrate clear ROI and identify where recalibration is needed.
RELATED INSIGHTS
Frameworks, articles, and case studies on Market Access Development.
Client Voice
WLH's pharma expertise is exceptional. They know the industry backwards and forwards — how it's structured, what the different roles are, how people interact with each other, and so on.
Matt Swift
Executive Director Market Access
MEASUREMENT & IMPACT
Measuring What Matters
We measure learning by its impact on performance, not participation. Our evaluation approach tracks outcomes across four levels to ensure programs deliver measurable business results.
Engagement
Participant satisfaction and engagement
Learning
Knowledge and skill acquisition
Behavior
On-the-job application and change
Results
Business outcomes and ROI
TRUSTED CLIENTS
Let’s Talk
Build capability that drives stronger performance
30 years of pharma and biotech-specific expertise. Custom-built programs. Measurable behavior change in the field.
